Will the high growth rate of Tongrentang's healthcare business be sustainable as it seeks to go public on the Hong Kong Stock Exchange?

On June 28th, Beijing Tongrentang Medical and Retirement Investment Co., Ltd. submitted its prospectus to the Hong Kong Stock Exchange, intending to list on the main board of the Stock Exchange, with China International Capital Corporation acting as its exclusive sponsor. As the third company under the Tongrentang Group to aim for a Hong Kong listing, the submission is expected to be smooth for Tongrentang Group, and the company aiming for the listing is a subsidiary that operates medical and retirement business. It is reported that Tongrentang Medical and Retirement is a medical institution that manages chain hospitals, basic-level chain medical institutions, and Internet hospitals. As of the last executable date, the company has 11 self-owned institutions.

金吾財訊Jul 5 04:36 ET

Beijing Tongrentang submitted an application for listing on the main board of the Hong Kong Stock Exchange for its healthcare business IPO.

Jingu Financial News | According to the disclosure of the Hong Kong Stock Exchange on June 28, Tongrentang Medical and Care submitted an application for listing on the Hong Kong Stock Exchange's main board, and China International Capital Corporation is the exclusive sponsor. The company is a leading traditional Chinese medicine medical group, with self-owned and managed medical institutions consisting of chain hospitals, grassroots chain medical institutions and internet hospitals. In terms of finance, the company recorded revenues of RMB 470 million, RMB 697 million and RMB 895 million in 2021-2023, with losses of RMB 6.793 million, RMB 14.66 million and profits of RMB 44.59 million in the same period.

金吾財訊Jun 27 20:54 ET

Beijing Tongrentang (600085.SH) equity distribution for 2023: 0.5 yuan per share.

Beijing Tongrentang (600085.SH) announced that the annual equity distribution for 2023 will be implemented according to the plan prior to...

Zhitong FinanceJun 21 04:33 ET

Tong Ren Tang Technology (01666): Feng Zhimei has been appointed as an executive director.

Zhitong Finance and Economics APP reported that Tong Ren Tang Technology (01666) announced that, effective June 12, 2024, (i) Di Shubing, Chen Jiafu and Feng Zhimei were appointed as executive directors of the ninth Board of Directors; (ii) Zhang Yi, Wang Chunrui and Feng Li were appointed as non-executive directors of the ninth Board of Directors; and (iii) Chen Qingxia, Zhan Yuanjing, and Li Zhaobin were appointed as independent non-executive directors of the ninth Board of Directors. Effective June 12, 2024, Guo Wen and Wu Yigang were appointed as shareholder representative supervisors of the ninth Supervisor Board. At the same time, the workers' representative group held on May 14, 2024

Zhitong FinanceJun 12 05:43 ET

Tong Ren Tang Technology (01666) will pay a final dividend of $0.18 per share on August 9

According to Zhitong Finance App, Tong Ren Tang Technology (01666) announced that the company will pay a final dividend of RMB 0.18 per share on August 9, 2024.

Zhitong FinanceMay 20 05:03 ET

China Merchants Securities: The 24Q1 Chinese medicine sector has steadily overcome high base pressure, and profit levels and dividends have improved markedly

The traditional Chinese medicine industry was slightly under pressure due to high base pressure in the short term, but the level of profit and dividends performed well. In the context of policies encouraging the inheritance, innovation and development of traditional Chinese medicine, along with the reform of state-owned enterprises and the implementation of catalytic events such as the basic drug catalogue, the traditional Chinese medicine sector is still cost-effective.

Zhitong FinanceMay 20 01:42 ET